Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 6

Effectiveness of Behavioral and Pharmacological Smoking Cessation Treatment in Patients with Failed Attempt at Quitting with E-cigarettes

Pages
404–408
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The remaining individuals were unable to quit smoking with pharmacological treatment, and the mean restarting time for these patients was 10.4±2.2 months.CONCLUSION: It has been shown that the success rate of smoking cessation increases with pharmacological treatment and behavioral/cognitive training in individuals who failed to quit smoking with e-cigarettes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: The tobacco industry has introduced electronic cigarettes (e-cigarettes) as a less harmful substitute to cigarettes and as an aid to smoking cessation.
📊
Key Findings & Data:This study aimed to evaluate the success of evidence-based pharmacological treatments and behavioral/cognitive training in patients who failed to quit smoking with e-cigarettes.MATERIAL AND METHODS: A total of 109 consecutive patients with failed attempts at smoking cessation by e-cigarettes were admitted.
💡
Conclusion & Impact:The remaining individuals were unable to quit smoking with pharmacological treatment, and the mean restarting time for these patients was 10.4±2.2 months.CONCLUSION: It has been shown that the success rate of smoking cessation increases with pharmacological treatment and behavioral/cognitive training in individuals who failed to quit smoking with e-cigarettes.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: The tobacco industry has introduced electronic cigarettes (e-cigarettes) as a less harmful substitute to cigarettes and as an aid to smoking cessation. This study aimed to evaluate the success of evidence-based pharmacological treatments and behavioral/cognitive training in patients who failed to quit smoking with e-cigarettes.MATERIAL AND METHODS: A total of 109 consecutive patients with failed attempts at smoking cessation by e-cigarettes were admitted. A questionnaire was administered to evaluate the demographic characteristics and smoking habits. Nicotine dependence scores of the smokers were obtained using the Fagerström addiction test. Appropriate pharmacological therapy and behavioral/cognitive training were given to each patient who failed to quit smoking with e-cigarettes.RESULTS: The mean age of the participants was 35.2±10.4 years, and 89 (81.7%) were men. Education level was high school or university for 92 (84.4%) patients; only 17 (15.6%) graduated from middle school. The mean number of cigarettes smoked per day was 25.8±10.8, and the mean nicotine dependence score was 6.7±1.9. Only 6 (5.5%) individuals quit smoking temporarily after using e-cigarettes, with a mean restarting time of 3.3±2.0 months in all 6 patients. The smoking cessation rate in our study was 43.1% (47 patients) with medical treatment. The remaining individuals were unable to quit smoking with pharmacological treatment, and the mean restarting time for these patients was 10.4±2.2 months.CONCLUSION: It has been shown that the success rate of smoking cessation increases with pharmacological treatment and behavioral/cognitive training in individuals who failed to quit smoking with e-cigarettes.

🔖

Cite This Article

ÇETİNKAYA, P. D., TURAN, A., DENİZ, P. P. (2022). Effectiveness of Behavioral and Pharmacological Smoking Cessation Treatment in Patients with Failed Attempt at Quitting with E-cigarettes. Turkish Thoracic Journal, Cilt: 21 - Sayı: 6, 404–408. https://ajindex.com/articles/618109

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. WHO Framework Convention on Tobacco Control. 2005. WHO Library Cataloguing-in-Publication Data, ISBN 978 92 4 159101 0
  2. Gilbert HA. (1965). Smokeless Non-Tobacco Cigarette. U.S. Patent No. 3,200,819. Washington, DC: U.S. Patent and Trademark Office
  3. Han L. (2012). Aerosol Electronic Cigarette. U.S. Patent No. 8,156,944. Washington, DC: U.S. Patent and Trademark Office
  4. Glasser AM, Katz L, Pearson JL, et al. Overview of electronic nicotine delivery systems: A systematic review. Am J Prev Med 2017;52:e33-e66. [Crossref] 5. Daglı E, Sönmez Peçe Ü, Güner M. Elektronik Sigara: Türkiye'de ve Dünyada Durum Analizi STED 2017; (26) özel sayı:12-17
  5. Gallus S, Lugo A, Pacifici R, et al. E-cigarette awareness, use, and harm perceptions in Italy: A national representative survey. Nicotine Tob Res 2014;16:1541-8. [Crossref] 7. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control 2014; May;23 Suppl 2:ii11-7. [Crossref] 8. Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2013;1291:48-55. [Crossref] 9. Trtchounian A, Talbot P. Electronic nicotine delivery systems: Is there a need for regulation? Tob Control 2011;20:47-52. [Crossref] 10. Grana R, Benowitz N, Glantz SA. E-cigarettes: A scientific review. Circulation 2014; 129:1972-86. [Crossref] 11. Bullen C, Howe C, Laugesen M et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. The Lancet 2013;382:1629-37. [Crossref] 12. Voigt K. Smoking Norms and the Regulation of E-Cigarettes. Am J Public Health 2015;105:1967-72. [Crossref] 13. Duke JC, Lee YO, Kim AE, et al. Exposure to electronic cigarette television advertisements among youth and young adults. Pediatrics 2014;134:e29-36. [Crossref] 14. Pisinger C, Dagli E, Filippidis FT, et al. ERS and tobacco harm reduction. Eur Respir J 2019;54:1902009. [Crossref] 15. Uysal M.A, Kadakal F, Karşidağ C, et al. Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis. Tuberk Toraks 2004;52:115-21
  6. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief 2015;217:1-8
  7. Pepper JK, Emery SL, Ribisl KM, Brewer NT. How U.S. adults find out about electronic cigarettes: implications for public health messages. Nicotine Tob Res 2014;16:1140-4. [Crossref] 18. Zhu SH, Gamst A Lee M, et al. The use and perception of electronic